“S” Stands for Systematic: Demystifying the Systematic Literature Review
In this webinar, experts present an overview of systematic literature reviews, detailing their purpose, execution, decision-making criteria, and suitability for addressing key questions in the pharmaceutical industry.
The race to develop combination vaccines – and the importance of indirect effects
By: Richard Pitman, PhD & Rosanna Barnard, PhD from ICON A development race is currently underway in the field [...]
Biden Administration Launches Global Health Security Strategy to Combat Infectious Diseases
The Biden administration has unveiled a comprehensive plan to strengthen global health security by assisting 50 [...]
Beyond Accelerated Approvals: External Control Arms
Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Hear four panelists discuss the role of integrated evidence generation in healthcare, focusing on its impact on patient outcomes and healthcare decision-making.
2024-2025 Top 10 HEOR Trends: ISPOR Report on Key Healthcare Decision-Making Factors
ISPOR, the Professional Society for Health Economics and Outcomes Research, published its “2024-2025 Top 10 HEOR [...]
Total System Value™ – A DYNAMIC APPROACH TO VALUE DEMONSTRATION
HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.
Total System Value™ – A DYNAMIC APPROACH TO VALUE DEMONSTRATION
HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.
FDA Launches START Program to Accelerate Development of Therapies for Rare Diseases
The FDA has launched the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) program, applying [...]
Novo Nordisk Invests $6 Billion in API Production Expansion to Meet High Demand
Novo Nordisk is investing over $6 billion to expand Denmark's active pharmaceutical ingredients (API) production capacity. [...]
Pfizer Announces Cost-Cutting Measures as Covid Vaccine and Antiviral Sales Decline
Pfizer has announced plans for a company-wide cost-cutting initiative this year and next due to expected [...]
Public Health Policies Aligned with Climate Change Mitigation: An Investment for Health and Economic Benefits
Investing in public health policies aligning with climate change mitigation measures is financially beneficial and crucial for human and planetary [...]
Medicare Price Negotiations for Drugs Begin in 2026: Eliquis Among Most Impacted
The Centers for Medicare & Medicaid Services (CMS) has disclosed a list of the initial ten drugs that will undergo [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
NHS’s MedTech Strategy: Building Resilience, Innovation, Infrastructure, and Focused Markets for UK’s Future in Medical Technology
The Med-Tech Innovation Expo in June presented the NHS's medtech strategy. The NHS released this strategy in February 2023 and [...]
Proposing a Revolution in American Healthcare: Universal Basic Health Coverage
MIT Professors Amy Finkelstein and Liran Einav have proposed a total overhaul of the U.S. health insurance system, advocating for [...]
Medical Affairs Outsourcing Market Forecasted to Reach $3.28B by 2027
The global Medical Affairs Outsourcing Market is forecast to reach $3,287.12 million by 2027 from $1,415.00 million in 2019, growing [...]
Economists Suggest That Universal Coverage Is Already Possible for the US: What Obstacles Still Stand in the Way?
The current state of health insurance in the U.S. needs to be revised, even for insured Americans who face the [...]
Sequoia Project and AHIMA Launch Health Data Usability Project
The Sequoia Project and the American Health Information Management Association (AHIMA) have partnered on the initiative "Data Usability Taking Root." [...]
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
Expert, Deepak Sahu answers questions on developing HEOR studies for generating short- and long-term effectiveness data for medical technology.
Podcast Q&A: Designing Causal Inference Studies Using Real-World Data
An expert panel answers questions on causal inference and designing these studies using real-world healthcare data.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.
Podcast Q&A: Evidence Generation Planning
Experts answer questions on evidence generation planning for clinical and commercial success and improvement of patient outcomes.
Industry Groups Challenge Readiness of ICER’s Value Framework
Healthcare is all about making decisions. Who to treat? When to treat? How to treat? How long to treat? How [...]
